For the third year running DDW is organising a series of seminars at SLAS International Conference and Exhibition. Based on the SLAS2026 theme of Catalyze Discovery, these will be available to visitors of SLAS2026 (7-11 February 2026, Boston, USA).

The programme – Creating Cures: The role of lab automation in successful drug discovery at SLAS2026 – will highlight innovative research using technology in drug development and will be held in the Ignite Theater on 9 and 10 February.

You can register your interest here.

Full speaker line-up:

Dr Preeti Ashok, Head of Cell Biology (Novoheart), Medera From Animal Models to Human Mini-Hearts: How Automated Human-Based Testing is Revolutionising Drug Discovery

Mel Leveridge, Vice President, Assays, Profiling & Cell Sciences, AstraZeneca The Role of Automation in Discovery at AstraZeneca

Kelly Bachovchin PhD, Customer Engagement Scientist, Collaborative Communications Interoperable Automation: Real-Time Dataflows to Close DMTA Cycles

Dr Gabe Musso, Chief Scientific Officer, Lunai Bioworks De-Risking the Translation Gap: Coupling AI with High-Throughput In Vivo Models

James Pena, Director, Product Management – Digital Science & Automation Solutions, Thermo Fisher Scientific From Data to Decisions: Digital-Ready Laboratories Powered by Automation

Mike Ouren, Director of Business Development, Brooks Automation Top Five Challenges to Consider When Automating Drug Discovery Lab Workflows

The track is sponsored by Collaborative Drug Discovery (CDD), Brooks Automation and Thermo Fisher Scientific.

Let us know if you’re attending by registering your interest.